Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Night sweats, Off label use, Pyrexia, SARS-CoV-2 test
Clinical narrative: injection site pain/soreness; insomnia; subjective fever; severe headache; constant; vomitting; malaise; constant; fatigue; Night sweats; CONSTANT; NAUSEA; administration date=05Oct2021,dose number=3;prev dose brand=MODERNA;prev dose dose number=2;prev dose dose number=1; administration date=05Oct2021,dose number=3;prev dose brand=MODERNA;prev dose dose number=2;prev dose dose number=1; This is a spontaneous report from a contactable Other HCP (patient himself). A 30-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: 391308A) via an unspecified route of administration, administered in Arm Left on 05Oct2021 12:30 (Age at Vaccination was 30 years) as dose 3 (booster), single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history included bipolar disorder type II, asthma (Exercise-Induced) all from an unknown date and unknown if ongoing. Concomitant medication received within 2 weeks of vaccination was none (It was stated that, any other medications he received within 2 weeks of vaccination was no change from doses 1 and 2). The patient historical vaccine included Moderna COVID-19 vaccine, (Lot Number: 013M20A), via an unspecified route of administration, administered in Arm Left on 16Feb2021 11:15 (Age at Vaccination was 29 years) as dose 2, single and Moderna COVID-19 vaccine, (Lot Number: 011L20A), via an unspecified route of administration, administered in Arm Left on 18Jan2021 12:15 (Age at Vaccination was 29 years) as dose 1, single for COVID-19 immunization. Patient previously took Penicillins, Amoxicillins and experienced known allergies. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. He was not diagnosed with COVID-19, prior to vaccination. He has been tested for COVID-19 since the vaccination. The patient experienced injection site pain/soreness, insomnia, subjective fever, severe headache, constant; vomitting, malaise, constant; fatigue, night sweats, constant; nausea on 05Oct2021 15:30, administration date=05oct2021,dose number=3;prev dose brand=moderna;prev dose dose number=2;prev dose dose number=1 on 05Oct2021. Reported as, injection site pain/soreness; insomnia x1 days; night sweats x2 days; insomnia x2 days; subjective fever x2 days; severe headache, constant; nausea, constant; vomitting, x2 instances, malaise, constant; fatigue, constant; all interfere with and/or prevent adl. aes current through time and date of submission only. not yet resolved. Patient has visited physician office as a result of events. Therapeutic measures were taken as a result of events for injection site pain/soreness, insomnia, subjective fever, severe headache, constant; vomitting, malaise, constant; fatigue, night sweats, constant; nausea which included NSAIDS, anti-nausea. The seriousness of the events was non-serious. The patient underwent lab tests and procedures which included Nasal Swab test: negative, (NAAT (local academic medical center)) on an unspecified date in Oct2021. The outcome of events injection site pain/soreness, insomnia, subjective fever, severe headache, constant; vomitting, malaise, constant; fatigue, night sweats, constant; nausea were not recovered. Follow-up attempts are completed. No further information is expected.